L-serine synthesis in the central nervous system: a review on serine deficiency disorders.
about
Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiencyDrug treatment of inborn errors of metabolism: a systematic reviewIdentification of a novel ligand binding site in phosphoserine phosphatase from the hyperthermophilic archaeon Thermococcus onnurineusDiagnostic approach to microcephaly in childhood: a two-center study and review of the literature.Integrative genomics identifies 7p11.2 as a novel locus for fever and clinical stress response in humansL-3-Phosphoserine phosphatase (PSPH) regulates cutaneous squamous cell carcinoma proliferation independent of L-serine biosynthesis.cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions.Comparative proteomic approach in rat model of absence epilepsy.Phenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistanceResurgence of serine: an often neglected but indispensable amino AcidEpileptogenesis in organotypic hippocampal cultures has limited dependence on culture medium composition.Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight.Metabolic causes of epileptic encephalopathyBrain proteomics supports the role of glutamate metabolism and suggests other metabolic alterations in protein l-isoaspartyl methyltransferase (PIMT)-knockout miceAn archaeal ADP-dependent serine kinase involved in cysteine biosynthesis and serine metabolism.Human HAD phosphatases: structure, mechanism, and roles in health and disease.Amino acid synthesis deficiencies.Discovery of safety biomarkers for realgar in rat urine using UFLC-IT-TOF/MS and 1H NMR based metabolomics.Adaptive response to l-serine deficiency is mediated by p38 MAPK activation via 1-deoxysphinganine in normal fibroblasts.Studies of Environmental Risk Factors in Amyotrophic Lateral Sclerosis (ALS) and a Phase I Clinical Trial of L-Serine.Mutations in SLC1A4, encoding the brain serine transporter, are associated with developmental delay, microcephaly and hypomyelination.A homozygous mutation in SLC1A4 in siblings with severe intellectual disability and microcephaly.Molecular cloning and expression of phosphoglycerate dehydrogenase and phosphoserine aminotransferase in the serine biosynthetic pathway from Acanthamoeba castellanii.De novo 393 kb microdeletion of 7p11.2 characterized by aCGH in a boy with psychomotor retardation and dysmorphic featuresL-serine deficiency caused by genetic Phgdh deletion leads to robust induction of 4E-BP1 and subsequent repression of translation initiation in the developing central nervous system.Natural Variation in SER1 and ENA6 Underlie Condition-Specific Growth Defects in Saccharomyces cerevisiae.Serine alleviates oxidative stress via supporting glutathione synthesis and methionine cycle in mice.Mechanisms of L-Serine Neuroprotection in vitro Include ER Proteostasis Regulation.D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression.Phase I clinical trial of safety of L-serine for ALS patients.Phosphoserine phosphatase (PSPH) gene mutation in an intellectual disability family from Pakistan.Inflammatory cytokine-mediated induction of serine racemase in atopic dermatitis.Analysis of Gene Expression Variance in Schizophrenia Using Structural Equation Modeling.
P2860
Q21134762-A3AD4CBA-3B07-4513-802E-154BA47C34D0Q26864796-4A9DE63B-FD7C-404D-A7A6-50A5915FDC4EQ27683600-6222FEFA-37A3-4D83-989B-E5CBF2558F90Q35117171-38D6F058-C442-4A55-86B4-47FD5FA61BBAQ35152830-EF503DD2-4372-42E0-882E-6BEB78EE131EQ35154253-EE110CF3-3DB8-4E38-B1F1-F832F87EFD17Q35291859-7AB17DD3-7074-417E-9A56-0AC5EDE066F0Q35342879-FF13F9CB-0C11-4EE0-ABFA-53DA366AC8C4Q35569960-4EDC543D-CE90-49DC-B3BE-6BC4003A3F43Q36016736-BAE84291-C161-4CB4-B985-E67CDB4D0E77Q36287500-061FD2E7-3455-434A-A85A-E35C00B2C572Q36353769-8376681E-B1C8-4593-963A-811E2D092FA2Q36908032-A195A6E2-31A4-4B35-BE76-0353DF87557DQ37282869-C0D55382-5DED-4EFB-B714-705D2C866292Q37430699-FE1F357A-B956-4F0B-AC45-87E239583719Q38011246-4023833C-1A40-4FB8-BF63-CDF976AE808EQ39400023-4057D28A-420D-4CEB-91F5-16AC98AAEC80Q39453822-F26DCA52-58EC-430F-B6AC-725BC3B72A23Q39881905-A5891534-ED7C-4757-86E6-61CE2D2B83FEQ40193214-4BBC9089-8AE6-4EA1-8FF0-D6234C83B2B7Q40871094-A989EAC4-A990-4ACB-94D4-CEE3D0051F09Q40990579-9EFEA93D-E96D-40F9-BEE5-A4B268A931C3Q41521574-CC3B7AAA-12D1-4814-92B7-23330C7C71AAQ41551222-D1BFC8C1-E0A0-4B7C-A03B-6B4358C49A59Q43763036-BC6F6B3C-9D83-4F12-8267-FDBCA166C333Q46130896-2986D742-08EB-4F8B-88B4-0EDA6E273319Q46328388-3BA115B8-342C-45BA-A017-5E53D2827DD5Q47446276-FDDFD78A-D3D6-4777-974E-FC0523AFCB75Q47838435-EA6DC4D6-EE70-4014-A105-711B460796FDQ48534203-B4A3822B-9AC2-4031-9508-A01B646CB31FQ48627361-A3074554-4EE3-4FB9-B912-FAF099653104Q55162625-66F123AA-8DCF-455C-B579-F8EFA75FF9ECQ55339033-72403FAA-5BF5-4CFB-8AC1-EFC19B7230C3
P2860
L-serine synthesis in the central nervous system: a review on serine deficiency disorders.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
L-serine synthesis in the cent ...... n serine deficiency disorders.
@ast
L-serine synthesis in the cent ...... n serine deficiency disorders.
@en
type
label
L-serine synthesis in the cent ...... n serine deficiency disorders.
@ast
L-serine synthesis in the cent ...... n serine deficiency disorders.
@en
prefLabel
L-serine synthesis in the cent ...... n serine deficiency disorders.
@ast
L-serine synthesis in the cent ...... n serine deficiency disorders.
@en
P2093
P1476
L-serine synthesis in the cent ...... n serine deficiency disorders.
@en
P2093
L Tabatabaie
T J de Koning
P304
P356
10.1016/J.YMGME.2009.10.012
P577
2009-10-25T00:00:00Z